Pascal and Francis Bibliographic Databases

Help

Export

Selection :

Permanent link
http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=23452240

Prolonged Drug Selection of Breast Cancer Cells and Enrichment of Cancer Stem Cell Characteristics

Author
CALCAGNO, Anna Maria1 ; SALCIDO, Crystal D2 ; GILLET, Jean-Pierre1 ; WU, Chung-Pu1 ; FOSTEL, Jennifer M3 ; MUMAU, Melanie D2 ; GOTTESMAN, Michael M1 ; VARTICOVSKI, Lyuba2 ; AMBUDKAR, Suresh V1
[1] Laboratory of Cell Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, United States
[2] Laboratory of Human Carcinogenesis, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, United States
[3] National Toxicology Program, National Institute of Environmental Health Sciences, National Institutes of Health, Research Triangle Park, NC, United States
Source

Journal of the National Cancer Institute. 2010, Vol 102, Num 21, pp 1637-1652, 16 p ; ref : 70 ref

ISSN
0027-8874
Scientific domain
Medical oncology
Publisher
Oxford University Press, Cary, NC
Publication country
United States
Document type
Article
Language
English
Keyword (fr)
Anticancéreux Cancer du sein Cancérologie Cellule souche Doxorubicine Enrichissement Homme Prolongé Résistance traitement Sélection Anthracyclines Cancer DNA topoisomerase (ATP-hydrolysing) Enzyme Inhibiteur de la topoisomérase II Inhibiteur enzyme Isomerases Pathologie de la glande mammaire Pathologie du sein Tumeur maligne
Keyword (en)
Antineoplastic agent Breast cancer Cancerology Stem cell Doxorubicin Enrichment Human Prolonged Treatment resistance Selection Anthracyclins Cancer DNA topoisomerase (ATP-hydrolysing) Enzyme Topoisomerase II inhibitor Enzyme inhibitor Isomerases Mammary gland diseases Breast disease Malignant tumor
Keyword (es)
Anticanceroso Cáncer del pecho Cancerología Célula primitiva Doxorubicina Enriquecimiento Hombre Prolongado Resistencia tratamiento Selección Antraciclinas Cáncer DNA topoisomerase (ATP-hydrolysing) Enzima Inhibidor topoisomerase II Inhibidor enzima Isomerases Glándula mamaria patología Seno patología Tumor maligno
Classification
Pascal
002 Biological and medical sciences / 002B Medical sciences / 002B02 Pharmacology. Drug treatments / 002B02R Antineoplastic agents / 002B02R01 General aspects

Pascal
002 Biological and medical sciences / 002B Medical sciences / 002B04 Tumors

Discipline
Pharmacological treatments Tumours
Origin
Inist-CNRS
Database
PASCAL
INIST identifier
23452240

Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS

Access to the document

Searching the Web